The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Been a gruelling wait to say the least but each day that passes us by without news is another day closer to what I hope will be a blockbuster RNS - keep the faith folks and trust in the research - if you don’t know why you’re here then I suggest you go to the casino and try roulette.
Good morning,
I see little benefit in building up expectations around the first sales RNS, it usually only leads to disappointment.
What is key with GDR is that their product has competitive advantage and is entering the market at a very good time for covid testing. This is particularly relevant because they are working towards both FDA and WHO Emergency Use approval. The second of which will give them far wider access to Africa and other lower middle income countries, which are long term markets for Covid testing because of their inability to control the spread, their lack of testing capacity and the likely longer period any successful vaccines, will require in order to be rolled out there. Personally, I believe GDR have a very good run at lower middle income countries for at least the next 12-18 months, with ongoing sales after that at a lower level, be they still potentially substantial.
Looking at NCYT, post CE Mark approval, they required c. 38 days to complete their FDA approval and c. 50 days to achieve WHO approval. GDR are currently at day 39.
No two businesses are the same but it gives a rough idea of what can be achieved and potentially how close these approvals are.
Given the product has only been on the market c. 5 weeks, as an investor, I don't expect block buster numbers in the first update. What I am looking for is market penetration and the foundations for bigger longer term sales, with the bonus being the signs that direct sales are there because that means greater revenue share.
All just my opinion.
Good morning BBN.
Yes, GDR is in the zone for big regulatory news.
The issue for management here is their business/selling acumen. They don't exactly have a stellar record of sales successes and mega distribution deals that are already pulling in £mns of revenue. Will the HCV WHO-approved test go the same way? A great product but so far no public declaration of any sales, or sales orders in the works. At least NCYT had sales orders pending regulatory approvals. They appear to be a mean sales operation, even if their product is not on the same level of technical quality as the GeneDrive96.
Show me the money, Mr Market is saying.
Excellent post BBN...... A little patience will go a long way here.
People will be losing patience. Originally the target for sales news was June. Before this got pushed back to June or July
"Following CE-IVD marking, the Company can commence commercial sales in the UK and across the EU immediately. The Company will now begin distribution to potential customers for initial clinical evaluations, and aims to record first commercial sales in June. "
Will do well to stay above 100p today, Oh dear.
Seems like the bottom here, but we will certainly find out today!
'Seems like the bottom here'
Don't jinx it!
To many panicking children on here, don’t listen to the negative spin they want your shares gla. June sales figures out within days.
Beginning of june shareprice 168. End of june shareprice 112. So in other words the market isnt impressed. First commercial sales suggested in june has proven to be just hot air Nd the market doesnt like it.
It does not matter how good a product is, if you cant get sales it is meaningless. Some say have patience but the performance of progress by gdr in last month is bad. We are in worldwide pandemic and no indication they have sold anything yet in a time where it should be fairly easy to obtain first commercial sales.
How low will this go before those first sales and how likely are is the market to now react given the sentiment in covid testing stocks has faded. There is no two ways to look at it, june has been a bad month for gdr and its shareholders.
AHH I think the worst ofbitbis over tbh, sales will come...
One thing I've learned over the last month is of you hear a rumor of these two words run! 'Placing' + 'Finncap'
Maybe spoke too soon.... Another ****ty day ahead... Thanks Finncap
The only people losing patience are traders....investors are more than happy to give DB the time he needs.
Closing deals only on IG sb unfortunately
Sell price currently 105 not 100 published. NT to buy
Agree BBN, and thanks for the video reminder ST, that’s why I bought in. Great product, patiently waiting... Let’s not forget GDR isn’t just about Covid too.
"The only people losing patience are traders....investors are more than happy to give DB the time he needs."
Utter nonsense. This is a traders dream. Look through the posts over the past few days man, even some of the longer term posters are getting a bit nervous.
only 18k sells (£20k worth)... and we are marked down...they are milking the pi's again
@O&W that is a perceived risk be it a worthy one. They need to prove themselves. However, whats more important is they have a product that has competitive advantages in a market that is in short supply. The HCV test has struggled to achieve sales but the two stories in terms of investment and demand, cannot be compared.
To fully exploit their target markets they need further regulatory approvals and there they have demonstrated previous successes.
RNS 4th Feb
"Indian regulatory approval for the HCV ID kit received in December 2019, bringing the total number of registered countries to 14"
4th May
"Genedrive® HCV-ID test receives WHO Prequalification."
So they have form be it that the HCV registrations took longer than anticipated. With Covid they shouldn't have the same issues because as I said, they are tackling these registrations at a time when higher quality, easier to use Covid testing is in high demand.
Right now HCV test sales have clearly been interrupted by the more pressing matter of Covid. Countries of wealth have delayed a great deal of 'non-essential' healthcare investment/operations. So the idea that lower middle income countries are fairing any better is for me highly likely.
For me, given sufficient time to breathe, this test will do very well and as the year develops, the prospect of the AIHL test completing its trials at Liverpool and Manchester, and achieving first sales, becomes ever more relevant here.
Rubbish punter... ive not sold a single share and topped up loads of times.... only traders and punters with T trades open are nervous and make easy pickings for the mm... Traders are getting spanked right now
Punter,how can you trade when IG are closing deals only?
"only 18k sells (£20k worth)... and we are marked down...they are milking the pi's again"
Interesting you didnt mention the number of buys.
Bought Value £0.00
Not one single share bought. Drop doesnt seem so silly now does it.
Punterwhat a load rubbish,18k should not drop the m cap 3 million !!
You are missing the point. MMs earn their crust when people buy and sell. If the holders are too stubborn to sell and judging by this board they are, they need to stimulate action by dropping the price to entice buyers. Given that the sentiment is dropping this price will be getting lower and lower. Obviously if sales news come through they will need to inrease the price to meet the demand as buyers some flooding back, probably.
Punter what screen are you looking at ?
buys are double the sells... 46.4K (£49k)
At the time you posted the sales numbers of £20k the buys were 0, and you know that full well.